Suzhou Zelgen Biopharmaceuticals Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is 440.21% vs 54.90% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is 2,259.04% vs 34.30% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "905.40",
          "val2": "167.60",
          "chgp": "440.21%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "630.00",
          "val2": "-49.30",
          "chgp": "1,377.89%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "6.00",
          "val2": "7.20",
          "chgp": "-16.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.60",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "632.60",
          "val2": "-29.30",
          "chgp": "2,259.04%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "695.90%",
          "val2": "-379.80%",
          "chgp": "107.57%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 50.99% vs 37.93% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is -9.85% vs 49.07% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "804.30",
          "val2": "532.70",
          "chgp": "50.99%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-191.00",
          "val2": "-162.70",
          "chgp": "-17.39%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "24.60",
          "val2": "29.10",
          "chgp": "-15.46%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.80",
          "val2": "3.90",
          "chgp": "-79.49%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-165.10",
          "val2": "-150.30",
          "chgp": "-9.85%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-306.70%",
          "val2": "-420.50%",
          "chgp": "11.38%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY

Mar'26

Mar'25

Change(%)

Net Sales

905.40

167.60

440.21%

Operating Profit (PBDIT) excl Other Income

630.00

-49.30

1,377.89%

Interest

6.00

7.20

-16.67%

Exceptional Items

0.60

0.00

Consolidate Net Profit

632.60

-29.30

2,259.04%

Operating Profit Margin (Excl OI)

695.90%

-379.80%

107.57%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Mar 2026 is 440.21% vs 54.90% in Mar 2025

Consolidated Net Profit

YoY Growth in quarter ended Mar 2026 is 2,259.04% vs 34.30% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

804.30

532.70

50.99%

Operating Profit (PBDIT) excl Other Income

-191.00

-162.70

-17.39%

Interest

24.60

29.10

-15.46%

Exceptional Items

0.80

3.90

-79.49%

Consolidate Net Profit

-165.10

-150.30

-9.85%

Operating Profit Margin (Excl OI)

-306.70%

-420.50%

11.38%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is 50.99% vs 37.93% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is -9.85% vs 49.07% in Dec 2024

All Annual Results